Specialized in the schematic development, organic synthesis, purification, and characterization of novel small-molecule drug candidates through extensive analytical expertise in ¹H NMR, ¹³C NMR, LC–MS, GC–MS, HPLC, and crystallography. Skilled in DFT, ADMET, and molecular docking simulation software for medicinal chemistry research. Lead organic synthesis efforts in collaborative precision vaccine discovery projects between University of Massachusetts Boston, Harvard Medical School, and Boston Children’s Hospital. Published 12+ peer-reviewed papers in Organic Letters, RSC Advances, ACS Omega and Journal of Molecular Structure. Committed to leveraging chemistry to develop novel solutions for patients. Laboratory Skills • Organic Synthesis: ¹H NMR, ¹³C NMR, Agilent 1290 LC-MS, GC-MS, HPLC, Size Exclusion Chromatography (SEC), Ion-Exchange (IEX), crystallography, Reversed Phase (RP)-HPLC small molecules, synthetic schemes, multicomponent reactions, catalytic multistep reactions, green synthesis, CAS SciFinder, Retrosynthesis, instrumental troubleshooting. • Computational Chemistry: DFT calculations, drug design related software (LiveDesign, Maestro, MOE, PyMOL, ELN, etc) molecular dynamics simulations, ADMET modeling, Peptide design, crystallographic software (e.g. CCDC suite, Olex2) • Collaboration & Communication: Cross-functional hit-to-lead and early drug discovery collaborations with biomedical research teams at Harvard Medical School and Boston Children’s Hospital focuse